Stephen Smolinski
2022 - Avalo Therapeutics
In 2022, Stephen Smolinski earned a total compensation of $990.9K as Former Chief Commercial Officer at Avalo Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $11,573 |
---|---|
Option Awards | $489,947 |
Salary | $74,242 |
Other | $415,117 |
Total | $990,879 |
Smolinski received $489.9K in option awards, accounting for 49% of the total pay in 2022.
Smolinski also received $11.6K in non-equity incentive plan, $74.2K in salary and $415.1K in other compensation.
Rankings
In 2022, Stephen Smolinski's compensation ranked 3,052nd out of 5,753 executives tracked by ExecPay. In other words, Smolinski earned more than 46.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,052 | 47th |
Manufacturing | 1,717 | 45th |
Chemicals And Allied Products | 806 | 43rd |
Drugs | 752 | 43rd |
Pharmaceutical Preparations | 546 | 44th |
Smolinski's colleagues
We found three more compensation records of executives who worked with Stephen Smolinski at Avalo Therapeutics in 2022.